Sign in
8-K

Current Report

SpyGlass Pharma, Inc. Filed Acc 0001628280-26-006460

Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure

  • Item 5.02 Departure or appointment of directors or officers
  • Item 5.03 Amendments to articles or bylaws; change in fiscal year
  • Item 7.01 Regulation FD disclosure

From the SEC's structured data for this filing

Loading spyglassclosing8-k.htm…